- Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
-
Nogami Y, Komatsu H, Makabe T, Hasegawa Y, Yokoyama Y, Kawana K, Okamoto A, Mikami M, Katabuchi H, The COVID-19 Task Force of the Japan Society of Gynecologic Oncology
- KMID: 2536014
- J Gynecol Oncol.
- 2022 Jan;33(1):e8.
- doi: 10.3802/jgo.2022.33.e8
Objective As coronavirus disease 2019 (COVID-19) rages on, it is a challenging task to balance resources for treatment of COVID-19 and malignancy-based treatment. For the development of optimal strategies, assessing the... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of menopause, aging and treatment procedures with positive margins after therapeutic cervical conization for CIN 3: a retrospective study of 8,856 patients by the Japan Society of Obstetrics and Gynecology
-
Ikeda M, Mikami M, Yasaka M, Enomoto T, Kobayashi Y, Nagase S, Yokoyama N, Katabuchi H
- KMID: 2526134
- J Gynecol Oncol.
- 2021 Sep;32(5):e68.
- doi: 10.3802/jgo.2021.32.e68
Objective The Japan Society of Obstetrics and Gynecology conducted a retrospective multi-institutional survey of patients who underwent cervical conization in Japan. This study aimed to determine the predictive factors for positive... -
- CITED
-
- Close
- SHARE
-
- Close
- Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis
-
Chiyoda T, Sakurai M, Satoh T, Nagase S, Mikami M, Katabuchi H, Aoki D
- KMID: 2511979
- J Gynecol Oncol.
- 2020 Sep;31(5):e67.
- doi: 10.3802/jgo.2020.31.e67
Objective: To assess the effectiveness of lymphadenectomy at primary debulking surgery (PDS) on the survival of patients with epithelial ovarian cancer (EOC). Methods: We searched PubMed, Ichushi, and the Cochrane Library.... -
- CITED
-
- Close
- SHARE
-
- Close
- The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee
-
Ikeda M, Shida M, Shigeta S, Nagase S, Takahashi F, Yamagami W, Katabuchi H, Yaegashi N, Aoki D, Mikami M
- KMID: 2526401
- J Gynecol Oncol.
- 2021 May;32(3):e44.
- doi: 10.3802/jgo.2021.32.e44
Objective: The Japan Society of Gynecologic Oncology published the first guidelines for the treatment of cervical cancer in 2007. The aim of this research was to evaluate the influence of... -
- CITED
-
- Close
- SHARE
-
- Close
- Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
-
Yamagami W, Mikami M, Nagase S, Tabata T, Kobayashi Y, Kaneuchi M, Kobayashi H, Yamada H, Hasegawa K, Fujiwara H, Katabuchi H, Aoki D
- KMID: 2465192
- J Gynecol Oncol.
- 2020 Jan;31(1):e18.
- doi: 10.3802/jgo.2020.31.e18
The Fourth Edition of the Guidelines for Treatment of Uterine Body Neoplasm was published in 2018. These guidelines include 9 chapters: 1. Overview of the guidelines, 2. Initial treatment for... -
- CITED
-
- Close
- SHARE
-
- Close
- The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer
-
Tokunaga H, Mikami M, Nagase S, Kobayashi Y, Tabata T, Kaneuchi M, Satoh T, Hirashima Y, Matsumura N, Yokoyama Y, Kawana K, Kyo S, Aoki D, Katabuchi H
- KMID: 2526387
- J Gynecol Oncol.
- 2021 Mar;32(2):e49.
- doi: 10.3802/jgo.2021.32.e49
The fifth edition of the Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer was published in 2020. The guidelines... -
- CITED
-
- Close
- SHARE
-
- Close
- A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma
-
Yamagami W, Nagase S, Takahashi F, Ino K, Hachisuga T, Mikami M, Enomoto T, Katabuchi H, Aoki D
- KMID: 2511956
- J Gynecol Oncol.
- 2020 Jul;31(4):e45.
- doi: 10.3802/jgo.2020.31.e45
Objective: International Federation of Gynecology and Obstetrics (FIGO) staging for ovarian, fallopian tube, and peritoneal cancers was revised in 2014. The aim of this study is to clarify whether the... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
-
Kobayashi Y, Masuda K, Hiraswa A, Takehara K, Tsuda H, Watanabe Y, Oda K, Nagase S, Mandai M, Okamoto A, Yaegashi N, Mikami M, Enomoto T, Aoki D, Katabuchi H, Working Group on Clinical Practice for Cancer Genomic Medicine and HBOC, Japan Society of Gynecologic Oncology
- KMID: 2537910
- J Gynecol Oncol.
- 2022 Sep;33(5):e61.
- doi: 10.3802/jgo.2022.33.e61
Objective The practices pertaining to hereditary breast and ovarian cancer (HBOC) in Japan have been rapidly changing owing to the clinical development of poly(ADP-ribose) polymerase inhibitors, the increasing availability of companion... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study
-
Machida H, Matsuo K, Oba K, Aoki D, Enomoto T, Okamoto A, Katabuchi H, Nagase S, Mandai M, Yaegashi N, Yamagami W, Mikami M
- KMID: 2536009
- J Gynecol Oncol.
- 2022 Jan;33(1):e3.
- doi: 10.3802/jgo.2022.33.e3
Objective Associations between hospital treatment volume and survival outcomes for women with 3 types of gynecologic malignancies, and the trends and contributing factors for high-volume centers were examined. Methods The Japan Society of... -
- CITED
-
- Close
- SHARE
-
- Close
